Multiple Manufacturers

HYALGAN

Manufacturer:

Multiple Manufacturers

Hyalgan HCPCS:

J7321

HCPCS Code Descriptor:

Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose

Category:

J Code

Hyalgan NDCs:

89122-0724-12, 89122-0724-20, 50016-0957-21, 89130-4444-01

Primary Type:

Orthopedic

Generic/Specialty Status:

Multi-Source

Package Type:

Not Found

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

89122-0724-12, 89122-0724-20, 50016-0957-21, 89130-4444-01

About Hyalgan:

HYALGAN is a medication manufactured by multiple manufacturers and aligned to the J Code: J7321. HYALGAN is administered via the injection route of administration.

Hyalgan is an injection that is indicated for the treatment of knee pain caused by osteoarthritis. Hyalgan is designed to mimic the fluid that surround the joints in the body. Hyalgan is thought to help act as a lubricant and a shock absorber for the knee joint, reducing pain and helping patients with osteoarthritis move more comfortably. Hyalgan is administered via injection directly into the joint of the knee.

ACCESS PRICING AND MORE BY REGISTERING

J7321 Added Date:

January 1, 2008

J7321 Effective Date:

April 1, 2021

J7321 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Hyalgan billing and coding information.
Hyalgan patient assistance information can be found through Fidia Pharma at the URL: http://www.hyalgan.com/
Our team is still working to identify a prescribing information source for HYALGAN
Our team has not yet identified a source of side effects information for HYALGAN. Please check back in a few weeks.